Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Inactivated Trivalent Influenza Vaccine in Pregnant Women
NCT00905125Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jun 2009
- Primary completion
- Mar 2010
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Fluzone Trivalent, Fluarix in influenza, sponsored by National Institute of Allergy and Infectious Diseases. Started Jun 2009; status: completed.
02
Drugs
Fluzone TrivalentFluarix
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00905125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00905125.